129 related articles for article (PubMed ID: 34559102)
1. Increased PYCR1 mRNA predicts poor prognosis in kidney adenocarcinoma: A study based on TCGA database.
Zhang T; Liu Y; Liu W; Li Q; Hou W; Huang Y; Lv P; Meng L; Li Y; Jia Y; Liu X; Zuo Z
Medicine (Baltimore); 2021 Sep; 100(38):e27145. PubMed ID: 34559102
[TBL] [Abstract][Full Text] [Related]
2. The clinical significance of PYCR1 expression in renal cell carcinoma.
Weijin F; Zhibin X; Shengfeng Z; Xiaoli Y; Qijian D; Jiayi L; Qiumei L; Yilong C; Hua M; Deyun L; Jiwen C
Medicine (Baltimore); 2019 Jul; 98(28):e16384. PubMed ID: 31305441
[TBL] [Abstract][Full Text] [Related]
3. PYCR1 knockdown inhibits the proliferation, migration, and invasion by affecting JAK/STAT signaling pathway in lung adenocarcinoma.
Gao Y; Luo L; Xie Y; Zhao Y; Yao J; Liu X
Mol Carcinog; 2020 May; 59(5):503-511. PubMed ID: 32133692
[TBL] [Abstract][Full Text] [Related]
4. PYCR in Kidney Renal Papillary Cell Carcinoma: Expression, Prognosis, Gene Regulation Network, and Regulation Targets.
Shao Z; Lu L; Cui Y; Deng L; Xu Q; Liang Q; Lu X; Zhang J; Chen J; Situ Y
Front Biosci (Landmark Ed); 2022 Dec; 27(12):336. PubMed ID: 36624948
[TBL] [Abstract][Full Text] [Related]
5. Human mitochondrial pyrroline-5-carboxylate reductase 1 promotes invasiveness and impacts survival in breast cancers.
Ding J; Kuo ML; Su L; Xue L; Luh F; Zhang H; Wang J; Lin TG; Zhang K; Chu P; Zheng S; Liu X; Yen Y
Carcinogenesis; 2017 May; 38(5):519-531. PubMed ID: 28379297
[TBL] [Abstract][Full Text] [Related]
6. Deciphering the effects of PYCR1 on cell function and its associated mechanism in hepatocellular carcinoma.
Xu Y; Zuo W; Wang X; Zhang Q; Gan X; Tan N; Jia W; Liu J; Li Z; Zhou B; Zhao D; Xie Z; Tan Y; Zheng S; Liu C; Li H; Chen Z; Yang X; Huang Z
Int J Biol Sci; 2021; 17(9):2223-2239. PubMed ID: 34239351
[TBL] [Abstract][Full Text] [Related]
7. Higher programmed cell death 1 ligand 1 (PD-L1) mRNA level in clear cell renal cell carcinomas is associated with a favorable outcome due to the active immune responses in tumor tissues.
Ning XH; Gong YQ; He SM; Li T; Wang JY; Peng SH; Chen JC; Liu JY; Qi NN; Guo YL; Gong K
Oncotarget; 2017 Jan; 8(2):3355-3363. PubMed ID: 27926518
[TBL] [Abstract][Full Text] [Related]
8. High expression levels of DEF6 predicts a poor prognosis for patients with clear cell renal cell carcinoma.
Zhu ZP; Lin LR; Lv TD; Xu CR; Cai TY; Lin J
Oncol Rep; 2020 Nov; 44(5):2056-2066. PubMed ID: 33000227
[TBL] [Abstract][Full Text] [Related]
9. PYCR1 interference inhibits cell growth and survival via c-Jun N-terminal kinase/insulin receptor substrate 1 (JNK/IRS1) pathway in hepatocellular cancer.
Zhuang J; Song Y; Ye Y; He S; Ma X; Zhang M; Ni J; Wang J; Xia W
J Transl Med; 2019 Oct; 17(1):343. PubMed ID: 31619254
[TBL] [Abstract][Full Text] [Related]
10. Knockdown of PYCR1 suppressed the malignant phenotype of human hepatocellular carcinoma cells via inhibiting the AKT pathway activation.
Guo J; Cheng X; Tian Y; Li B; Zhang X; Gao X; An Y
Reprod Biol; 2021 Sep; 21(3):100534. PubMed ID: 34271243
[TBL] [Abstract][Full Text] [Related]
11. PYCR1, BANF1, and STARD8 Expression in Gastric Carcinoma: A Clinicopathologic, Prognostic, and Immunohistochemical Study.
Harb OA; Elfeky MA; Alabiad MA; Hemeda R; Allam AS; El Hawary AT; Elbaz M; Sharaf AL; Gertallah LM; Abdelaziz AM; Shalaby AM; Alorini M; Yahia AIO; Negm M
Appl Immunohistochem Mol Morphol; 2024 Feb; 32(2):102-110. PubMed ID: 37982568
[TBL] [Abstract][Full Text] [Related]
12. Identification of C3 and FN1 as potential biomarkers associated with progression and prognosis for clear cell renal cell carcinoma.
Dong Y; Ma WM; Yang W; Hao L; Zhang SQ; Fang K; Hu CH; Zhang QJ; Shi ZD; Zhang WD; Fan T; Xia T; Han CH
BMC Cancer; 2021 Oct; 21(1):1135. PubMed ID: 34688260
[TBL] [Abstract][Full Text] [Related]
13. Identification of lncRNA TRPM2-AS/miR-140-3p/PYCR1 axis's proliferates and anti-apoptotic effect on breast cancer using co-expression network analysis.
Sun T; Song Y; Yu H; Luo X
Cancer Biol Ther; 2019; 20(6):760-773. PubMed ID: 30810442
[TBL] [Abstract][Full Text] [Related]
14. Pyrroline-5-Carboxylate Reductase 1 Accelerates the Migration and Invasion of Nonsmall Cell Lung Cancer
Sang S; Zhang C; Shan J
Cancer Biother Radiopharm; 2019 Aug; 34(6):380-387. PubMed ID: 30916574
[No Abstract] [Full Text] [Related]
15. Decreased SPTLC1 expression predicts worse outcomes in ccRCC patients.
Zhu WK; Xu WH; Wang J; Huang YQ; Abudurexiti M; Qu YY; Zhu YP; Zhang HL; Ye DW
J Cell Biochem; 2020 Feb; 121(2):1552-1562. PubMed ID: 31512789
[TBL] [Abstract][Full Text] [Related]
16. Expression of chemokine receptor 4 was associated with poor survival in renal cell carcinoma.
Liu Q; Rexiati M; Yang Y; Wang WG; Azhati B; Saimaiti W; Wang YJ
Med Oncol; 2014 Apr; 31(4):882. PubMed ID: 24554520
[TBL] [Abstract][Full Text] [Related]
17. A five-gene signature predicts overall survival of patients with papillary renal cell carcinoma.
Gao Z; Zhang D; Duan Y; Yan L; Fan Y; Fang Z; Liu Z
PLoS One; 2019; 14(3):e0211491. PubMed ID: 30822312
[TBL] [Abstract][Full Text] [Related]
18. A Gene Signature of Survival Prediction for Kidney Renal Cell Carcinoma by Multi-Omic Data Analysis.
Hu F; Zeng W; Liu X
Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31739630
[TBL] [Abstract][Full Text] [Related]
19. Prognostic implications of Aquaporin 9 expression in clear cell renal cell carcinoma.
Xu WH; Shi SN; Xu Y; Wang J; Wang HK; Cao DL; Shi GH; Qu YY; Zhang HL; Ye DW
J Transl Med; 2019 Nov; 17(1):363. PubMed ID: 31703694
[TBL] [Abstract][Full Text] [Related]
20. Effects of PYCR1 on prognosis and immunotherapy plus tyrosine kinase inhibition responsiveness in metastatic renal cell carcinoma patients.
Xu X; Wang Y; Hu X; Zhu Y; Wang J; Guo J
Neoplasia; 2023 Sep; 43():100919. PubMed ID: 37517099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
